About Marizyme
Marizyme is a company based in Woodstock (United States) founded in 2007.. The company has 11 employees as of December 31, 2023. Marizyme has completed 2 acquisitions, including My Health Logic and Somahlution. Marizyme operates in a competitive market with competitors including Organogenesis, Sofregen, Encellin, BioTissue and Reapplix, among others.
- Headquarter Woodstock, United States
- Employees 11 as on 31 Dec, 2023
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Marizyme Inc
-
Annual Revenue
$233.49 K11as on Dec 31, 2022
-
Net Profit
-
EBITDA
$841.44 K1818as on Dec 31, 2022
-
Latest Funding Round
$1 M (USD), Post-IPO
May 18, 2023
-
Investors
-
Employee Count
11
as on Dec 31, 2023
-
Investments & Acquisitions
My Health Logic
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Marizyme
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $1.0M
-
First Round
First Round
(12 Sep 2018)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Post-IPO - Marizyme | Valuation |
investors |
|
| May, 2023 | Amount | Post-IPO - Marizyme | Valuation |
investors |
|
| Oct, 2021 | Amount | Post-IPO - Marizyme | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Marizyme
Marizyme has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include My Health Logic and Somahlution. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Chronic kidney disease management and assessment services are provided.
|
2020 | ||||
|
Therapeutics for Vascular graft disease
|
2010 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Marizyme
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Marizyme Comparisons
Competitors of Marizyme
Marizyme operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Organogenesis, Sofregen, Encellin, BioTissue and Reapplix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative therapies for wound care are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Silk-derived biomaterials are developed for soft tissue repair in surgery.
|
|
| domain | founded_year | HQ Location |
Developer of regenerative materials
|
|
| domain | founded_year | HQ Location |
Regenerative biologic therapies for eye care are developed and provided.
|
|
| domain | founded_year | HQ Location |
Developer of patch system for wound healing
|
|
| domain | founded_year | HQ Location |
Synthetic electrospun scaffolds are provided for regenerative medical uses.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Marizyme
Frequently Asked Questions about Marizyme
When was Marizyme founded?
Marizyme was founded in 2007 and raised its 1st funding round 11 years after it was founded.
Where is Marizyme located?
Marizyme is headquartered in Woodstock, United States. It is registered at Woodstock, New York, United States.
Who is the current CEO of Marizyme?
Michael K Handley is the current CEO of Marizyme.
How many employees does Marizyme have?
As of Dec 31, 2023, the latest employee count at Marizyme is 11.
What is the annual revenue of Marizyme?
Annual revenue of Marizyme is $233.49K as on Dec 31, 2022.
What does Marizyme do?
Founded in 2007 and based in Woodstock, United States, Marizyme operates in the biotechnology sector focused on medical therapies. Proteolytic enzyme treatments, such as Krillase, are developed for chronic wound debridement, thrombolysis, and oral hygiene improvement. Krillase, classified as a Class III medical device, incorporates endopeptidases and exopeptidases to break down biofilms and promote healing. Operations emphasize enzyme-based solutions for wound care and dental applications.
Who are the top competitors of Marizyme?
Marizyme's top competitors include Organogenesis, GeniPhys and Acera Surgical.
How many acquisitions has Marizyme made?
Marizyme has made 2 acquisitions, including My Health Logic, and Somahlution.